Tezted

Tezted is a Finnish diagnostics company developing and commercializing in vitro tests for infectious and complex diseases, with an emphasis on tick-borne disease diagnostics. Its lead commercial product, TICKPLEX, is a CE-IVD-marked ELISA-based multiplex test designed to detect Lyme disease, tick-borne co-infections, and related opportunistic microbes through partner laboratories. The company has also offered SARSPLEX, a SARS-CoV-2 antibody ELISA for research use. Tezted presents itself as a university spinout founded in 2016 and operating under ISO 13485:2016 quality standards. Overall, the business is best characterized as a private healthcare diagnostics company serving clinical laboratories and providers rather than a therapeutic drug developer.